Back
Corporate News
Suven Pharmaceuticals receives credit ratings from CRISIL
28-Feb-2025, 07:46
Suven Pharmaceuticals announced that CRISIL has assigned/ reaffirmed the following ratings to the Bank facilities of the Company as under:
Suven Pharmaceuticals announced that CRISIL has assigned/ reaffirmed the following ratings to the Bank facilities of the Company as under:
Long Term Rating - CRISIL A+/Watch Positive (Continues on 'Rating Watch with Positive Implications')
Short Term Rating - CRISIL A1+ (Reaffirmed)
Powered by Capital Market - Live News